| 1 |
ECHA (European Chemical Agency) (2019) Toxicological Information (Triclosan). Available from: https://echa.europa.eu/registration-dossier/-/registered-dossier/12675/1/./
|
|
| 2 |
ECHA (European Chemical Agency) (2019) Carcinogenicity (triclosan). Available from: https://echa.europa.eu/registration-dossier/-/registered-dossier/12675/7/8/?documentUUID=7f7a0e59-5295-4cfa-b2e2-d167a4fc2d8c/./
|
|
| 3 |
Park, M., Kim, S., Kim, Y., Nam, D.J., Ryoo, J.H. and Lim, S. (2019) Relationship between personal care products usage and triclosan exposure: the second Korean National Environmental Health Survey (KoNEHS 2012-2014). Ann. Occup. Environ. Med., 31, 2./
|
|
| 4 |
Kim, D.Y., Kim, J.H., Lee, J.C., Won, M.H., Yang, S.R., Kim, H.C. and Wie, M.B. (2019) Zinc oxide nanoparticles exhibit both cyclooxygenase-and lipoxygenase-mediated apoptosis in human bone marrow-derived mesenchymal stem cells. Toxicol. Res., 35, 83-91./
|
|
| 5 |
Nishioka, K., Koizumi, A. and Takita, Y. (2019) Allergic contact dermatitis caused by cysteamine hydrochloride in permanent wave agent-A new allergen for hairdressers in Japan. Contact Derm., 80, 174-175./
|
|
| 6 |
Miura, T., Suemizu, H., Goto, M., Sakai, N., Iwata, H., Shimizu, M. and Yamazaki, H. (2019) Human urinary concentrations of monoisononyl phthalate estimated using physiologically based pharmacokinetic modeling and experimental pharmacokinetics in humanized-liver mice orally administered with diisononyl phthalate. Xenobiotica, 49, 513-520./
|
|
| 7 |
Kamiya, Y., Otsuka, S., Miura, T., Takaku, H., Yamada, R., Nakazato, M., Nakamura, H., Mizuno, S., Shono, F., Funatsu, K. and Yamazaki, H. (2019) Plasma and hepatic concentrations of chemicals after virtual oral administrations extrapolated using rat plasma data and simple physiologically based pharmacokinetic models. Chem. Res. Toxicol., 32, 211-218./
|
|
| 8 |
Miura, T., Uehara, S., Nakazato, M., Kusama, T., Toda, A., Kamiya, Y., Murayama, N., Shimizu, M., Suemizu, H. and Yamazaki, H. (2019) Human plasma and liver concentrations of styrene estimated by combining a simple physiologically based pharmacokinetic model with rodent data. J. Toxicol. Sci., 44, 543-548./
|
|
| 9 |
Miura, T., Uehara, S., Mizuno, S., Yoshizawa, M., Murayama, N., Kamiya, Y., Shimizu, M., Suemizu, H. and Yamazaki, H. (2019) Steady-state human pharmacokinetics of monobutyl phthalate predicted by physiologically based pharmacokinetic modeling using single-dose data from humanized-liver mice orally administered with dibutyl phthalate. Chem. Res. Toxicol., 32, 333-340./
|
|
| 10 |
Agency for Toxic Substances and Disease Registry (2019) Toxicological Profile for 1,2-Dichloropropane, Atlanta, GA, USA. Available from: http://www.atsdr.cdc.gov/ToxProfiles/tp.asp?id=831&tid=162/./
|
|